BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33393045)

  • 1. MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy.
    Hata T; Mizuma M; Masuda K; Chiba K; Ishida M; Ohtsuka H; Nakagawa K; Morikawa T; Kamei T; Unno M
    Ann Surg Oncol; 2021 Apr; 28(4):2235-2245. PubMed ID: 33393045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial Comment on: MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy.
    Yokobori T
    Ann Surg Oncol; 2021 Apr; 28(4):1882-1883. PubMed ID: 33249524
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-Abdominal Metastases.
    Chiba K; Hata T; Mizuma M; Masuda K; Aoki S; Takadate T; Kawaguchi K; Nakagawa K; Morikawa T; Motoi F; Furukawa T; Unno M
    Ann Surg Oncol; 2022 Apr; 29(4):2685-2697. PubMed ID: 34739641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancer.
    Clark CJ; Traverso LW
    Am J Surg; 2010 May; 199(5):657-62. PubMed ID: 20466112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-194-5p in Pancreatic Ductal Adenocarcinoma Peritoneal Washings is Associated with Peritoneal Recurrence and Overall Survival in Peritoneal Cytology-Negative Patients.
    Kubo H; Hiroshima Y; Mori R; Saigusa Y; Murakami T; Yabushita Y; Sawada Y; Homma Y; Kumamoto T; Matsuyama R; Endo I
    Ann Surg Oncol; 2019 Dec; 26(13):4506-4514. PubMed ID: 31489551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytology of peritoneal lavage performed during staging laparoscopy for gastrointestinal malignancies: is it useful?
    Nieveen van Dijkum EJ; Sturm PD; de Wit LT; Offerhaus J; Obertop H; Gouma DJ
    Ann Surg; 1998 Dec; 228(6):728-33. PubMed ID: 9860470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer.
    Tanemura M; Furukawa K; Mikamori M; Asaoka T; Yasuoka H; Marukawa D; Urata Y; Yamada D; Kobayashi S; Eguchi H
    Sci Rep; 2024 May; 14(1):10199. PubMed ID: 38702437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of minute cancer cell dissemination in peritoneal lavage fluid detected by reverse transcription PCR is an independent prognostic factor in patients with resectable pancreatic cancer.
    Eguchi H; Ohigashi H; Takahashi H; Yano M; Motoori M; Miyashiro I; Kishi K; Ohue M; Noura S; Seki Y; Yamada T; Goto K; Yamamoto T; Idota A; Fujii J; Nakajima H; Yamasaki T; Ishikawa O
    Surgery; 2009 Nov; 146(5):888-95. PubMed ID: 19744431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting positive peritoneal cytology in pancreatic cancer.
    O'Halloran EA; Board T; Lefton M; Devarajan K; Dotan E; Meyer J; Reddy SS
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1825-1832. PubMed ID: 33389074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Impact of Positive Peritoneal Lavage Cytology on Resectable Pancreatic Body and Tail Cancer: A Retrospective Study.
    Mashiko T; Ogasawara T; Masuoka Y; Ei S; Takahashi S; Hirabayashi K; Mori M; Koyanagi K; Yamamoto S; Nakagohri T
    World J Surg; 2023 Mar; 47(3):729-739. PubMed ID: 36357802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Peritoneal Staging for Pancreatic Ductal Adenocarcinoma Using Mutant KRAS Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical Trial.
    Yonkus JA; Alva-Ruiz R; Abdelrahman AM; Leiting JL; Schneider AR; Grotz TE; Cleary SP; Smoot RL; Nagorney DM; Kendrick ML; Kipp BR; Truty MJ
    J Am Coll Surg; 2021 Jul; 233(1):73-80.e1. PubMed ID: 34022414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive impacts of peritoneal washing cytology for surgical resection-intended pancreatic cancer cases: Establishment of planned staging laparoscopy criteria.
    Tanaka N; Takami H; Hayashi M; Inokawa Y; Kurimoto K; Hattori N; Kanda M; Tanaka C; Nakayama G; Kodera Y
    J Hepatobiliary Pancreat Sci; 2023 Nov; 30(11):1273-1281. PubMed ID: 37799038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
    Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
    PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer.
    Pak LM; Coit DG; Eaton AA; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Strong VE; Kingham TP
    Ann Surg Oncol; 2017 May; 24(5):1174-1179. PubMed ID: 28058561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
    Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
    [No Abstract]   [Full Text] [Related]  

  • 16. Laparoscopy and peritoneal cytology in the staging of pancreatic cancer.
    Jimenez RE; Warshaw AL; Fernandez-Del Castillo C
    J Hepatobiliary Pancreat Surg; 2000; 7(1):15-20. PubMed ID: 10982586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incremental benefit of two quadrant lavage for peritoneal cytology at staging laparoscopy for oesophagogastric adenocarcinoma.
    Munasinghe A; Kazi W; Taniere P; Hallissey MT; Alderson D; Tucker O
    Surg Endosc; 2013 Nov; 27(11):4049-53. PubMed ID: 23836122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of staging laparoscopy for resectable pancreatic cancer on imaging and the therapeutic effect of systemic chemotherapy for positive peritoneal cytology.
    Fukasawa M; Watanabe T; Tanaka H; Itoh A; Kimura N; Shibuya K; Yoshioka I; Murotani K; Hirabayashi K; Fujii T
    J Hepatobiliary Pancreat Sci; 2023 Nov; 30(11):1261-1272. PubMed ID: 37750024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor DNA as a predictive marker for occult metastases in pancreatic cancer patients with radiographically non-metastatic disease.
    Hata T; Mizuma M; Iseki M; Takadate T; Ishida M; Nakagawa K; Hayashi H; Morikawa T; Motoi F; Unno M
    J Hepatobiliary Pancreat Sci; 2021 Aug; 28(8):648-658. PubMed ID: 34022116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: A nationwide, cancer registry-based study from the Japan Pancreas Society.
    Tsuchida H; Fujii T; Mizuma M; Satoi S; Igarashi H; Eguchi H; Kuroki T; Shimizu Y; Tani M; Tanno S; Tsuji Y; Hirooka Y; Masamune A; Mizumoto K; Itoi T; Egawa S; Kodama Y; Hamada S; Unno M; Yamaue H; Okazaki K;
    Surgery; 2019 Dec; 166(6):997-1003. PubMed ID: 31445763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.